Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes.
Pharmacogenomics., Mar;12(3):327-39 (2011)
Randomized trial of 2 dosages of prophylactic granulocyte-colony-stimulating factor after induction chemotherapy in pediatric acute myeloid leukemia.
Cancer., Mar;117(6):1313-20 (2011)
Efficacy of high-dose methotrexate, ifosfamide, etoposide and dexamethasone salvage therapy for recurrent or refractory childhood malignant lymphoma.
Ann. Oncol., Feb;22(2):468-71 (2011)
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.
Lancet Oncol., Jun;11(6):543-52 (2010)
Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia.
Cancer., Jan;116(1):98-105 (2010)
Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial.
Leukemia., Aug;23(8):1410-6 (2009)
Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.
Leukemia., Jun;23(6):1127-30 (2009)
Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital.
Blood., May;113(21):5083-9 (2009)
Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis.
Cancer., Aug;113(3):522-9 (2008)
Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia.
Cancer., Jul;113(2):376-82 (2008)
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma.
Blood., Jan;111(2):566-73 (2008)
Creating a palliative and end-of-life program in a cure-oriented pediatric setting: the zig-zag method.
J Pediatr Oncol Nurs., 24(5):246-54 (2007 Sep-Oct)
Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemia.
Pediatr Blood Cancer., Mar;50(3):542-8 (2008)
BK virus-induced tubulointerstitial nephritis in a child with acute lymphoblastic leukemia.
J. Pediatr., Aug;151(2):215-7 (2007)
Nocturnal awakenings, sleep environment interruptions, and fatigue in hospitalized children with cancer.
Oncol Nurs Forum., Mar;34(2):393-402 (2007)
Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.
J. Clin. Oncol., Apr;25(10):1183-9 (2007)
Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia.
JAMA., Mar;297(11):1207-15 (2007)
Clinical field testing of an enhanced-activity intervention in hospitalized children with cancer.
J Pain Symptom Manage., Jun;33(6):686-97 (2007)
Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia.
Cancer., Jan;109(1):157-63 (2007)
Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia.
Blood., Dec;108(13):3997-4002 (2006)